Development and Validation of A Simple Clinical Risk Prediction Model for New-Onset Postoperative Atrial Fibrillation...

Area of Science:

• Cardiology
• Cardiac Surgery
• Clinical Risk Prediction

Background:

• Postoperative atrial fibrillation (POAFib) affects 20-40% of cardiac surgery patients, increasing morbidity and mortality.
• Accurate prediction of POAFib is crucial for targeted prophylactic strategies.

Purpose of the Study:

• To develop and validate a simple clinical risk score for predicting POAFib after cardiac surgery.
• To identify key clinical predictors of POAFib.

Main Methods:

• Retrospective cohort study of 6,509 cardiac surgery patients (2004-2017).
• Logistic regression used to develop the NOPAF score on 75% of the data.
• Validation performed on the remaining 25% of patients; discrimination and calibration assessed.

Main Results:

• The NOPAF score identified age, cardiopulmonary bypass, reduced LVEF, renal disease, and heart failure as risk factors; statin use was protective.
• The NOPAF score demonstrated good discrimination (AUC 0.71 derivation, 0.67 validation) and excellent calibration.
• POAFib incidence varied significantly by risk category: 5% (low), 11% (intermediate), and 27.7% (high) in derivation; 5.7%, 12.6%, and 23.6% in validation.

Conclusions:

• The NOPAF score is a validated, simple clinical tool for stratifying POAFib risk in cardiac surgery patients.
• This score can aid in identifying high-risk individuals for intensified postoperative atrial fibrillation prophylaxis.